KDIGO. Blood Pressure in CKD. The KDIGO 2021 Blood Pressure in CKD Guideline. Chaired by Cheung A and Mann J. 2021. https://kdigo.org/guidelines/blood-pressure-in-ckd/
SPRINT Research Group, et al. A randomized trial of intensive versus standard blood pressure control. N Engl J Med 2015; 373:2103–2116. doi: 10.1056/NEJMoa1511939
Blood Pressure Lowering Treatment Trialists' Collaboration, et al. Blood pressure lowering and major cardiovascular events in people with and without chronic kidney disease: Meta-analysis of randomised controlled trials. BMJ 2013; 347:f5680. doi: 10.1136/bmj.f5680
Whelton PK, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018; 71:e127–e248. https://www.jacc.org/doi/pdf/10.1016/j.jacc.2017.11.006
Myer MG, et al. Measurement of blood pressure in the office: Recognizing the problem and proposing the solution. Hypertension 2010; 55:195–200. doi: 10.1161/HYPERTENSIONAHA.109.141879
Albasri A, et al. Association between antihypertensive treatment and adverse events: Systematic review and meta-analysis. BMJ 2021; 372:n189. doi: 10.1136/bmj.n189
Foti KE, et al. Potential implications of the 2021 KDI GO blood pressure guideline for adults with chronic kidney disease in the United States. Kidney Int 2021; 99:686–695. doi: 10.1016/j.kint.2020.12.019